Litcius/Paper detail

Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis

Amar U Kishan, Yilun Sun, Holly Hartman, Thomas M Pisansky, Michel Bolla, Anouk Neven, Allison Steigler, James W Denham, Felix Y Feng, Almudena Zapatero, John G Armstrong, Abdenour Nabid, Nathalie Carrier, Luis Souhami, Mary T Dunne, Jason A Efstathiou, Howard M Sandler, Araceli Guerrero, David Joseph, Philippe Maingon, Theo M de Reijke, Xavier Maldonado, Ting Martin Ma, Tahmineh Romero, Xiaoyan Wang, Matthew B Rettig, Robert E Reiter, Nicholas G Zaorsky, Michael L Steinberg, Nicholas G Nickols, Angela Y Jia, Jorge A Garcia, Daniel E Spratt

2022The Lancet Oncology181 citationsDOIOpen Access PDF

Topics & Concepts

MedicineProstate cancerDuration (music)Androgen deprivation therapyRadiation therapyProstateOncologyInternal medicineAndrogenPatient dataCancerProstate diseaseProstate-specific antigenGynecologyHormonal therapyProstatectomyMEDLINEProstate Cancer Diagnosis and TreatmentProstate Cancer Treatment and ResearchAdvanced Radiotherapy Techniques
Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis | Litcius